Search Results
Oct 30, 2025, 08:01 ET PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025
commercial-stage medical technology company operating in the medical device, diagnostics, and digital health sectors. Its subsidiary, Lucid Diagnostics (Nasdaq: LUCD), is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal
More news about: PAVmed Inc.
Oct 29, 2025, 08:01 ET Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced
More news about: Lucid Diagnostics
Oct 15, 2025, 08:01 ET Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today
More news about: Lucid Diagnostics
Sep 25, 2025, 08:01 ET Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced
More news about: Lucid Diagnostics
Sep 16, 2025, 08:01 ET Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced
More news about: Lucid Diagnostics
Sep 11, 2025, 09:17 ET Lucid Diagnostics Announces Closing of Public Offering of Common Stock
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced
More news about: Lucid Diagnostics
Sep 10, 2025, 08:00 ET Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced
More news about: Lucid Diagnostics
Sep 09, 2025, 16:01 ET Lucid Diagnostics Announces Proposed Public Offering of Common Stock
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced
More news about: Lucid Diagnostics